 |
Articles: Pharmacoeconomics |
Potential Clinical and Economic Outcomes of CYP2C9 and VKORC1 Genotype-Guided Dosing in Patients Starting Warfarin Therapy
Clinical Pharmacology & Therapeutics, 07/02/09
Prior Articles
Rapid Infliximab Infusions in Pediatric Inflammatory Bowel Disease
Journal of Pediatric Gastroenterology and Nutrition, 07/01/09
Estimation of economic costs associated with transfusion dependence in adults with MDS
Current Medical Research and Opinion, 07/01/09 Long-term cost-effectiveness of clopidogrel in STEMI patients
International Journal of Cardiology, 06/30/09 Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK
Current Medical Research and Opinion, 06/30/09 Insomnia-related comorbidities and economic costs among a commercially insured population in the United States
Current Medical Research and Opinion, 06/29/09 Costs of second-generation antihistamines in the treatment of allergic rhinitis: US perspective
Current Medical Research and Opinion, 06/26/09 A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US
Current Medical Research and Opinion, 06/25/09 Absenteeism and health-benefit costs among employees with MS
Current Medical Research and Opinion, 06/25/09 Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting
Current Medical Research and Opinion, 06/25/09 Cost and utilization of COPD and asthma among insured adults in the US
Current Medical Research and Opinion, 06/24/09 Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs
Current Medical Research and Opinion, 06/24/09 Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER
Current Medical Research and Opinion, 06/24/09 Cost-Effectiveness of Routine Rapid Human Immunodeficiency Virus Antibody Testing Before DNA-PCR Testing for Early Diagnosis of Infants in Resource-Limited Settings
Pediatric Infectious Disease Journal, 06/24/09 Cost effectiveness and budget impact of natalizumab in patients with relapsing multiple sclerosis
Current Medical Research and Opinion, 06/23/09 Economic evaluations of hepatitis B vaccination for developing countries
Expert Review of Vaccines, 06/23/09 Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the united states
Clinical Therapeutics, 06/23/09 Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
BMC Pregnancy and Childbirth, 06/22/09
Free full text
Use and cost of erythropoiesis-stimulating agents in patients with cancer
Current Medical Research and Opinion, 06/19/09 Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: Administrative claims analysis
Current Medical Research and Opinion, 06/19/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
140 Available Pages
|
|
